~~<i id='B92AB74942'><strike id='B92AB74942'><tt id='B92AB74942'><pre id='B92AB74942'></pre></tt></strike></i>~~

Home» explore» leisure time

leisure time

author：explore 2025-09-29 17:14:29 Page View：888

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： RaDonda Vaught to speak at CommonSpirit event on patient safety
Next article： At least 13 dead in Texas as scorching temps continue

explore

Medicare details structure of new drug price negotiation program

MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

Obesity now affects over 1 billion people worldwide, study finds

AdobeMorethan1billionpeople—oroneineightpeopleworldwide—arenowestimatedtohaveobesity,anewstudyfinds.

Psychedelics group wrestles with new pharma identity

OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

Biden will tout long

FILE-TheGrandCanyonNationalParkiscoveredinthemorningsunlightasseenfromahelicopternearTusayan,Ariz.,O